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Introduction: Acinetobacter baumannii is a nosocomial pathogen that usually affects
critically ill patients. High mortality rates have been associated with MDR A. baumannii
infections. Carbapenem resistance among these isolates is increasing worldwide and
is associated with certain International Clones (ICs) and oxacillinases (OXAs). Moreover,
this organism possesses a wide range of virulence factors, whose expression is not yet
fully understood. In this study, clinical A. baumannii isolates are characterized in terms of
antibiotic resistance, mechanisms of carbapenem resistance, clonality, and virulence.
Materials and Methods: A. baumannii clinical isolates (n = 90) where obtained from
a tertiary care center in Beirut, Lebanon. API 20NE strips in addition to the amplification
of blaOXA−51−like were used for identification. Antibiotic susceptibility testing by disk
diffusion was then performed in addition to PCRs for the detection of the most commonly
disseminated carbapenemases. Clonality was determined by tri-locus PCR typing and
doubling times were determined for isolates with varying susceptibility profiles. Biofilm
formation, hemolysis, siderophore production, proteolytic activity, and surface motility
was then determined for all the isolates. Statistical analysis was then performed for the
determination of associations.
Results and Discussion: 81 (90%) of the isolates were resistant to carbapenems.
These high rates are similar to other multi-center studies in the country suggesting
the need of intervention on a national level. 74 (91.3%) of the carbapenem resistant
isolates harbored blaOXA−23−like including two that also harbored blaOXA−24−like. 88.9%
of the A. baumannii isolates pertained to ICII and three other international clones
were detected, showing the wide dissemination of clones into geographically distinct
locations. Virulence profiles were highly diverse and no specific pattern was observed.
Nevertheless, an association between motility, siderophore production, and biofilm
formation was detected (p < 0.05).
Conclusions: A very high rate of carbapenem resistance was detected, showing the
need for immediate intervention. IC II and OXA-23-like were the most disseminated,
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reflecting their international dissemination. No specific associations were made between
virulence and resistance, but instead associations among certain virulence factors
were found. Investigating a more clonally diverse pool of isolates could help in the
determination of associations between virulence and resistance.
Keywords: Acinetobacter baumannii, carbapenem resistance, virulence, clonality, oxacillinases
INTRODUCTION
Acinetobacter baumannii is a nosocomial pathogen that could
cause severe secondary infections among critically ill patients
(Gordon and Wareham, 2010). This organism has a wide range
of intrinsic resistance mechanisms and a heightened ability to
acquire resistance to a broad range of antimicrobial agents
(Peleg et al., 2012). Mortality rates among critically ill patients
infected with Multi-Drug Resistant (MDR) A. baumannii are
high, especially when improper empirical treatments are given
(Ñamendys-Silva et al., 2015).
Carbapenems have been the treatment of choice for treating
critically ill patients with MDR A. baumannii infections (Breilh
et al., 2013). However, the increasing rates of Carbapenem
Resistant A. baumannii (CRAB) isolates (Tärnberg et al., 2016)
have limited their efficacy and increased mortality rates among
infected patients (Lemos et al., 2014). Oxacillinases (OXAs)
are the most commonly identified mechanism of carbapenem
resistance among A. baumannii isolates. These OXAs include
OXA-23-like, OXA-24-like, and OXA-58-like (Nowak and
Paluchowska, 2016). A. baumannii also harbors the intrinsic
blaOXA−51−like in its genome. This OXA is highly conserved
among A. baumannii strains (Turton et al., 2006a), but does
not convey resistance to carbapenems unless associated with
insertion sequences (Turton et al., 2006b). A few globally
disseminated International Clones (ICs) have been found to
cause most CRAB infections worldwide and have been associated
with the presence of these OXAs (Karah et al., 2012).
A global surveillance program showed that Europe and
the Mediterranean regions harbored the highest rate of MDR
A. baumannii isolates (Flamm et al., 2016). Moreover, IC II
was found to be widely disseminated among these countries (Di
Popolo et al., 2011). This clone was also found to be largely
disseminated in Lebanon (Rafei et al., 2014). Moreover, CRAB
isolates were found to increase in prevalence in this country
throughout the past decade (Hamouche and Sarkis, 2012). In
2012, 88% of 724 A. baumannii isolates recovered from various
Lebanese hospitals were found to be resistant to imipenem
(Hammoudi et al., 2015a). Although OXA-24-like (Hammoudi
et al., 2015b) and OXA-58-like (Zarrilli et al., 2008) have been
detected in this country, OXA-23-like seems to be the most
prevalent among CRAB isolates (Rafei et al., 2015).
In addition to the various mechanisms of resistance
detected among A. baumannii isolates, this organism can
deferentially express various virulence factors. These factors
include biofilm formation, surface motility, hemolysis on blood
agars, siderophore production, and exoprotease activity; among
others (Antunes et al., 2011). Whole genome sequencing and
insertional mutagenesis led to the identifying of 28 genetic
islands coding for genes predicted to be involved in virulence
in this organism. Disruption of 6 of these islands did indeed
result in avirulent isolates, as shown by infection models using
Caenorhabditis elegans and Dictyostelium discoideum (Smith
et al., 2007). Among the genes within these islands, genes
coding for type IV secretion systems, which are associated with
surface motility (Eijkelkamp et al., 2011a), are also found. Of
note, A. baumannii was shown to produce different patterns of
motility, depending on the choice (Difco Bacto or Eiken) or
concentration of the agar (Clemmer et al., 2011). Also among
the genes involved in virulence detected in A. baumannii, are
genes coding for hemolysins/hemagglutinins (Smith et al., 2007).
The expression of these genes was reported on blood agar plates
and in liquid assays (Antunes et al., 2011). Exoprotease activity
was also reported for A. baumannii strains in the previous study,
after prediction of the presence of exoprotease genes in the A.
baumannii genome (Antunes et al., 2011).
Siderophore production, mainly through the biosynthesis of
acinetobactin, was also identified as a virulence determinant in
A. baumannii. Successful biosynthesis of this siderophore was
shown to be needed for the induction of apoptosis of epithelial
cells. Moreover, impairment of siderophore production was
shown to reduce the ability of A. baumannii to persist in and
kill the host, as shown through infection models using Galleria
mellonella larvae (Gaddy et al., 2012). Biofilm formation, though
at different rates and patterns, has also been reported among
A. baumannii clinical isolates (Dahdouh et al., 2016). Several
loci in the A. baumannii genome have been implicated with the
production of biofilms. One such locus is that coding poly-β-
(1-6)-N-acetylglucosamine, an important component of biofilms,
and a virulence factor that is involved in cell to cell adherence
and protection from host defenses (Bentancor et al., 2012).
Impairment of biofilm production, in addition to pili synthesis
and motility, was shown to attenuate virulence in mammalian
septicemia models (Cerqueira et al., 2014).
The relationship between virulence and antimicrobial
resistance seems to be a highly complex one that is still
not completely understood (Peleg et al., 2012). Importantly,
the effect of harboring OXAs on virulence in A. baumannii
is not well defined (Beceiro et al., 2013). The aim of this
study is to characterize A. baumannii isolates obtained from
a Lebanese hospital in terms of antibiotic susceptibility,
carbapenemases harbored, clonality, and virulence determinants.
Moreover, the relationship between virulence and carbapenem
resistance will be explored. This would help in providing
clinicians and infection control specialists with crucial data
that would allow for the development of successful empirical
treatments and infection control measures. Moreover, our
findings could open the way for the exploitation of the
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interplay between virulence and resistance in the clinical
setting.
MATERIALS AND METHODS
Bacterial Strains
Ninety five non-repetitive A. baumannii clinical isolates were
obtained from Saint George University—University Medical
Center (SGH-UMC) over a period extending from June 2013
until August 2014. The isolates were obtained from various
patient specimens that include sputum, pus, urine, and blood.
The strains were identified using 20NE API strips (BioMérieux,
France). The isolates that were not identified as Acinetobacter
calcoaceticus—A. baumannii by the biochemical tests were not
selected for further investigation. Amplification of the intrinsic
blaOXA−51−like gene by PCR was then performed in order to
verify that the isolate is A. baumannii (Turton et al., 2006a). The
isolates were then stored at −20◦C in Luria-Bertani (LB) Broth
supplemented with 20% glycerol until used.
Antimicrobial Susceptibility Testing
The Kirby Bauer disk diffusion method was performed
according to the CLSI guidelines (2014) in order to determine
the Antibiotic Susceptibility Profiles (ASTs) of the isolates.
The results were interpreted according to the cutoff values
of the CLSI document M100-S24 (Clinical and Laboratory
Standards Institute, 2014). Antimicrobial agents tested for
were cefotaxime (30 µg), ceftazidime (30 µg), cefepime (30
µg), piperacillin/tazobactam (100/10 µg), meropenem (10 µg),
imipenem (10 µg), trimethoprim/sulfamethoxazole (1.25/23.75
µg), ciprofloxacin (5 µg), gentamycin (10 µg), and colistin (10
µg). In order to verify resistance to colistin, E-tests (BioMérieux
Mercy l’Etoile, France) and minimum inhibitory concentrations
by broth microdilution were performed for isolates that showed
narrow inhibition zones around the colistin disks.
Polymerase Chain Reactions
PCRs for the detection of blaOXA−51−like (Turton et al., 2006a);
blaOXA−23−like, blaOXA−24−like, and blaOXA−58−like (Mostachio
et al., 2009); and blaOXA−48, blaNDM, and blaKPC (Poirel et al.,
2011) as previously described by the respective authors were
performed. International lineage was determined using tri-locus
PCR typing as described by Turton et al. (2007). The table
summarized by Karah et al. (2012) was used in order to assign the
international clonality of the tested isolates. For all PCR reactions,
a commercial master mix was used (Qiagen, USA) and the
primers, in addition to their respective annealing temperatures,
are shown in Table 1. The PCR conditions were an initial
elongation at 94◦C for 3 min; followed by 30 cycles of 94◦C for
45 s, the respective annealing temperature (Table 1) for 45 s, and
72◦C for 1 min; and a final extension step at 72◦C for 5 min. For
the blaOXA−48, blaNDM, and blaKPC genes, the number of cycles
was increased to 36, and the annealing time was increased to 50 s
(Poirel et al., 2011). Positive controls for the respective genes were
used from previous studies (Moubareck et al., 2009; Hammoudi
et al., 2015b).
Growth Curves
In order to calculate the doubling time for selected isolates
with varying antibiotic susceptibility profiles, 1:100 dilutions
from overnight cultures liquid cultures in fresh LB broth were
performed. The fresh suspensions were then incubated at 37◦C
with shaking at 200 rpm for 8 h. Each hour, the OD600 was
measured and the doubling times were calculated from the
resulting curve as previously described (Hall et al., 2014). The
growth curves and all the following experiments were performed
in triplicates.
Biofilm Formation
Biofilm formationwas detected in polystyrene tubes after staining
with crystal violet as previously described (Tomaras et al., 2003).
Briefly, 1 mL of inoculated LB broth was incubated overnight at
37◦C and then washed and stained with 1% crystal violet for 10
min. The dye was then rinsed away and biofilms were visualized
and graded as “++” if heavy stains were observed and as “+” if
faint stains were observed.
Hemolytic Activity
Hemolytic activity on blood agar plates were tested for by
inoculating 10 µL of a bacterial suspension adjusted to 106
CFU/mL in the center of these plates. The plates were then
incubated for 6 days at 37◦C and observed daily (Taybali et al.,
2012).
Siderophore Production
Siderophore production in a liquid medium using the Chrome
Azurol Solution (CAS) was performed as previously described
(Louden et al., 2011). 5 mL of the PMS7-Ca medium was
inoculated and incubated for 72 h. The suspension was then
centrifuged at 4000× g for 10min and 1mL of the filter-sterilized
supernatant was incubated 1:1 with the CAS. The OD630 was
then measured and a 10% difference between the sample and
un-inoculated PMS7-Ca with CAS was considered as positive
(Machuca and Milagres, 2003).
Surface Motility
For the detection of surface motility, a single colony was
grown in LB broth overnight at 37◦C. The visual turbidity
of the suspension was then adjusted to be equivalent to the
0.5McFarland standard, in order to contain around 108 CFU/mL.
1µL (105 CFU/mL) of the bacterial suspension was then
inoculated on freshly prepared 0.3% LB-Agar (Difco, BD, USA)
plates. The plates were then incubated at 37◦C for 14 h and
the diameter of the circular diffusion pattern was measured
(Clemmer et al., 2011).
Proteolytic Activity
Proteolytic activity was determined by inoculating 5 mL of
Trypticase Soy Broth Dyalisate with one colony and incubating
it overnight at 37◦C with shaking at 200 rpm. The following day,
the suspension was centrifuged at 4000 × g for 10 min and 500
µL of the filter-sterilized supernatant was incubated with 500 µL
of 1 mg/mL Azoalbumin dissolved in 50 mM Tris-HCl (pH =
7.7). This preparation was incubated at 37◦C for 24 h and 13%
trichloroacetic acid was then added. The tubes were incubated
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TABLE 1 | Primers used in this study with their respective annealing temperatures.
Primer Sequence Annealing Temperature References
Oxa-51-like-F 5′-ATGAACATTAAAGCACTC-3′ 46◦C Turton et al., 2006b
Oxa-51-like-R 5′-CTATAAAATACCTAATTGTTC-3′
Oxa-23-like-F 5′-GATCGGATTGGAGAACCAGA-3′ 53◦C Mostachio et al., 2009
Oxa-23-like-R 5′-ATTTCTGACCGCATTTCCAT-3′
Oxa-24-like-F 5′-GGTTAGTTGGCCCCCTTAAA-3′ 53◦C Mostachio et al., 2009
Oxa-24-like-R 5′-AGTTGAGCGAAAAGGGGATT-3′
Oxa-58-like-F 5′-AAGTATTGGGGCTTGTGCTG-3′ 53◦C Mostachio et al., 2009
Oxa-58-like-R 5′-CCCCTCTGCGCTCTACATAC-3′
KPC-F 5′-CGTCTAGTTCTGCTGTCTTG-3′ 52◦C Poirel et al., 2011
KPC-R 5′-CTTGTCATCCTTGTTAGGCG-3′
NDM-F 5′-GGTTTGGCGATCTGGTTTTC-3′ 52◦C Poirel et al., 2011
NDM-R 5′-CGGAATGGCTCATCACGATC-3′
Oxa-48-F 5′-GCGTGGTTAAGGATGAACAC-3′ 52◦C Poirel et al., 2011
Oxa-48-R 5′-CATCAAGTTCAACCCAACCG-3′
Group1ompAF306 5′-GATGGCGTAAATCGTGGTA-3′ 57◦C Turton et al., 2007
Group1and2ompAR660 5′-CAACTTTAGCGATTTCTGG-3′
Group1csuEF 5′-CTTTAGCAAACATGACCTACC-3′ 57◦C Turton et al., 2007
Group1csuER 5′-TACACCCGGGTTAATCGT-3′
Gp1OXA66F89 5′-GCGCTTCAAAATCTGATGTA-3′ 57◦C Turton et al., 2007
Gp1OXA66R647 5′-GCGTATATTTTGTTTCCATTC-3′
Group2ompAF378 5′-GACCTTTCTTATCACAACGA-3′ 57◦C Turton et al., 2007
Group1and2ompAR660 5′-CAACTTTAGCGATTTCTGG-3′
Group2csuEF 5′-GGCGAACATGACCTATTT-3′ 57◦C Turton et al., 2007
Group2csuER 5′-CTTCATGGCTCGTTGGTT-3′
Gp2OXA69F169 5′-CATCAAGGTCAAACTCAA-3′ 57◦C Turton et al., 2007
Gp2OXA69R330 5′-TAGCCTTTTTTCCCCATC-3′
at −20◦C for 20 min and centrifuged at 15,000 × g for 10 min.
The OD440 of the supernatant was then measured and U/L values
were calculated where one U was the amount of enzyme needed
to degrade one micromole of Azoalbumin (Ronca-Testoni, 1983;
Antunes et al., 2011)
Statistical Analysis
Normality of the data, when applicable, was tested for using
the Shapiro-Wilk test. One-way ANOVA and student t-tests
were performed for normally distributed data while the Kruskal-
Wallis and Mann-Whitney tests were performed non-normally
distributed data. Qualitative data was analyzed using the chi
squared and the two-sided Fisher’s exact tests. P-values of less
than 0.05 were considered as statistically significant and all tests
were performed using the SPSS program, version 17.0 (SPSS 111
Inc., Chicago, USA).
RESULTS
Bacterial Isolates
In total, 95 Acinetobacter spp. isolates were collected. Of
these isolates, three were Acinetobacter haemolyticus, one
was Acinetobacter junii/johnsonii, and one was Acinetobacter
radioresistens/lwoffii as identified by the API strips. The rest of
the isolates (n = 90) were A. baumannii as identified by API
and the subsequent amplification of blaOXA−51−like (Turton et al.,
2006a). Thirty five (38.9%) A. baumannii isolates were collected
in 2013 while fifty five (61.1%) were collected in 2014. Fifty eight
(64.5%) of theA. baumannii isolates were collected from sputum,
17 (18.9%) from pus, 9 (10%) from urine, and 4 (4.4%) from
blood samples. Two (2.2%) isolates were collected from catheters.
Thirty six (40%) of the isolates were obtained from the ICU, 33
(36.7%) from general medicine, 10 (11.1%) from the surgical unit,
9 (10%) from the geriatric unit, 1 (1.1%) from the psychiatric unit,
and 1 (1.1%) from the pediatric unit.
Antibiotic Susceptibility
Antibiotic susceptibility profiles were obtained after testing
by the Kirby Bauer disk diffusion method according to CLSI
guidelines (2014). Eighty one (90%) of the A. baumannii
isolates were resistant to both meropenem and imipenem. Only
one isolate was resistant to colistin. Susceptibility to other
antimicrobial agents tested for was very low and did not exceed
14.4% (Table 2). Antibiotic susceptibility profiles are found in
Supplementary Table 1.
Dissemination of Carbapenemases and
International Clones
PCRs for the detection of the most common carbapenemases
among A. baumannii were performed in addition to tri-locus
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TABLE 2 | Antibiotic susceptibility profiles for 90 A. baumannii isolates collected over a 1-year period.
ANTIMICROBIAL AGENT
CTX CAZ FEP TZP MEM
n % n % n % n % n %
Resistant 79 87.8 78 86.7 58 64.4 81 90 81 90
Intermediate 9 10 1 1.1 19 21.1 2 2.2 0 0
Sensitive 2 2.2 11 12.2 13 14.4 7 7.8 9 10
ANTIMICROBIAL AGENT
IMP SXT CIP GT COL
n % n % n % n % n %
Resistant 81 90 83 92.2 84 93.3 77 85.6 1 1.1
Intermediate 0 0 0 0 0 0 0 0 0 0
Sensitive 9 10 7 7.8 6 6.7 13 14.4 89 98.9
CTX stands for cefotaxime, CAZ for ceftazidime, FEP for cefepime, TZP for piperacillin/tazobactam, MEM for meropenem, IMP for imipenem, SXT for trimethoprim/sulfamethoxazole,
CIP for ciprofloxacin, GT for gentamycin, and COL for colistin.
PCR typing which determines international clonality. Of the 81
A. baumannii isolates that showed resistance to carbapenems,
74 (91.3%) harbored blaOXA−23−like. Two of these isolates
additionally harbored blaOXA−24−like. These are isolates 42 and
49. None of the other carbapenemases tested for were detected.
Seven isolates were resistant to carbapenems but did not harbor
any of the tested carbapenemases (Isolates 54, 59, 68, 72, 83, 84,
and 85). Two isolates were sensitive to carbapenems but harbored
blaOXA−23−like (Isolates 17 and 87).
Eighty A. baumannii isolates (88.9%) pertained to IC II,
whereas six (6.7%) pertained to group 4 (Isolates 11, 25, 39, 62,
82, and 91), one (1.1%) to group 10 (Isolate 56), and two (2.2%)
to group 14 (Isolates 42 and 72), as summarized by Karah et al.
(2012) (Table 3). One A. baumannii isolate showed a pattern
that did not pertain to any IC where CsuE and blaOXA−66 were
amplified from the first multiplex, and the other allele of CsuE
was also amplified from the second multiplex.
Virulence Determinants in Relation with
Clonality and Carbapenem Susceptibility
The result of the various virulence determinants, in addition
to international clonality and carbapenem resistance, are shown
in Table 3. Seventy seven (85.6%) of the A. baumannii isolates
showed strong biofilm formations while 10 (11.1%) showed weak
formations and 3 (3.3%) showed no biofilm formation. Forty
two (46.7%) of the A. baumannii isolates showed α-hemolysis on
blood agar plates while one isolate showed β-hemolysis. Seventy
two (80%) A. baumannii isolates showed a diffusion pattern
indicating surface motility on 0.3% LB-Agar while 52 (57.8%)
isolates were positive for siderophore production. Proteolytic
activity ranged from 4.4± 1.63 U/L to 61.97± 12.65 U/L and the
doubling times for selected isolates ranged from 0.262± 0.021 to
0.653± 0.049 h.
No general pattern was observed between the doubling times
and antibiotic susceptibility profiles. The slowest doubling time
was determined for isolate 28 which was carbapenem-resistant,
α-hemolytic, produced strong biofilms, showed a motility
pattern, harbored blaOXA−23−like, and pertained to IC II.
Nevertheless, other isolates with similar profiles showed faster
doubling times (Table 3). One such example is isolate 78 which
incidentally had the fastest doubling time. The colistin-resistant
isolate 75 showed a similar antibiotic susceptibility pattern and
virulence profile to the aforementioned two isolates and had a
relatively fast doubling time of 0.328± 0.076 h.
Figure 1 shows representative isolates for non-motile,
moderately motile, and highly motile isolates. Isolate 94 showed
the highest motility diffusion diameter (144.5 ± 7.7 mm on
a 15 cm square petri dish), produced strong biofilms, showed
hemolysis on blood agars, and had a relatively high proteolytic
activity (26.37 ± 4.42 U/L). This isolate was susceptible to
carbapenems and pertained to IC II. Isolate 5 was the only isolate
that showed β-hemolysis and it had the highest proteolytic
activity. It also showed a motility diffusion pattern, produced
strong biofilms and siderophores, pertained to IC II, and
harbored blaOXA−23−like. Isolates 2, 3, 4, 11, 12, and 82 showed
very modest to no motility diffusion patterns and were negative
for hemolysis. Isolate 4 also had a slow doubling time (0.594
± 0.036 h). However, not all isolates that had similar motility
diffusion diameters shared the rest of the virulence profile with
these isolates.
Two of the isolates that pertained to group 4 were susceptible
to carbapenems and four out of six isolates of this group
were negative for siderophore production. Moreover, another
two isolates of this group were negative for biofilm formation.
Four of the six isolates pertaining to this group harbored
blaOXA−23−like and were resistant to carbapenems. The isolate
pertaining to group ten was susceptible to carbapenems and
showed elevated levels of virulence determinants. Both isolates
pertaining to Group 14 had similar profiles but one was negative
for blaOXA−23−like but positive for hemolysis whereas the other
harbored blaOXA−23−like and blaOXA−24−like but was negative
for hemolysis. Isolate 18, which did not pertain to any of the
international clones by tri-locus sequence typing was susceptible
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TABLE 3 | Virulence determinants of 90 A. baumannii isolates in addition to international clonality and carbapenem resistance.
Isolate IC Carb R. Bio Hemo Sidero Motility (mm) Proteo (U/L) DT (hours)
2 2 + + – + 8± 0.7 7.66±1.81
3 2 + ++ – + 7.5± 0.7 25.32±4.22
4 2 + ++ – + 9.1± 0.5 28.9±6.34 0.594± 0.036
5 2 + ++ β/D1 + 18.1± 2.8 61.97±12.65
7 2 + ++ α/D3 + 8.6± 1.2 23.68±10.74
8 2 + + α/D2 + 9.1± 1.1 20.56±7.32 0.471± 0.067
10 2 + ++ α/D2 + 20.8± 3.3 5.59±3.68
11 4 – ++ – + 6.4± 0.5 21.15±2.06
12 2 + ++ – + 8.2± 1 3.33±1.61
13 2 + + α/D3 + 48.4± 2.6 7.47±2.98 0.403± 0.056
14 2 + ++ α/D2 + 8± 0.9 26.22±1.86
15 2 + ++ – – 8.2± 0.8 32.28±5.44 0.539± 0.063
16 2 + ++ α/D3 + 14.2± 2 23.48±1.96
17 2 – ++ – + 23.2± 1.4 16±1.39 0.283± 0.031
18 - – ++ – + 25± 2.8 22.47±3.39
19 2 + ++ – + 12.8± 0.6 23.24±4.1
20 2 + ++ α/D2 + 23.3± 1.7 30.69±6.94
21 2 + ++ – + 43.1± 2.2 27.26±0.63 0.377± 0.031
22 2 – + – + 6.7± 0.8 5.98±5.45 0.310± 0.063
23 2 + ++ α/D2 + 6.8± 0.7 24.71±3.38
24 2 + ++ – + 16.9± 0.9 5.26±1.42
25 4 + ++ α/D2 + 26.1± 1.5 21.45±3.9
26 2 + ++ – + 27.8± 1.5 8.72±0.3
27 2 + ++ – + 22.9± 1.3 18.32±0.63
28 2 + ++ α/D2 – 27.5± 1.4 10.53±4.43 0.653± 0.049
29 2 + ++ – + 27.3± 1.5 32.27±10.28
30 2 + ++ – + 18.8± 1 7.08±3.31
31 2 + ++ – + 23.6± 2.1 27.71±3.9
32 2 + ++ – – 30.3± 2.3 23.77±1.77
33 2 + ++ α/D2 + 37.7± 1.9 19.04±2.15
34 2 + ++ – + 25.1± 1.5 23.24±9.42
35 2 + ++ – + 24.4± 1.6 26.51±1.86
36 2 + ++ α/D2 + 41.5± 2.3 7.49±4.58
37 2 + ++ – + 29.1± 2.4 23.24±4.47
38 2 + ++ – + 25.6± 1.4 10.59±3.46
39 4 + – α/D3 – 10.3± 1.7 6.9±2.4
40 2 + ++ – + 27.4± 1.9 6.68±1.93
41 2 + ++ α/D2 – 23.3± 1.5 9.09±2.32 0.401± 0.030
42 14 + ++ – + 23.2± 2.1 20.85±4.92
43 2 + + α/D3 + 30.6± 2.2 21.15±7.6
44 2 + ++ – – 32± 2.4 19.48±2.78 0.467± 0.039
45 2 + ++ – + 28.9± 2.3 4.72±2.17
46 2 + ++ – + 25.1± 1.5 11.05±4.5
47 2 + ++ α/D2 + 30.8± 2.3 15.94±6.88
48 2 + ++ α/D2 + 26± 1.6 11.65±4.2
49 2 + ++ – + 19.2± 0.9 11.72±4.99 0.343± 0.120
51 2 + ++ – + 22.4± 1.5 24.43±2.73
52 2 + ++ α/D2 + 26± 2.2 9.43±3.22
53 2 + ++ α/D2 + 23.6± 2.4 11.4±4.09
54 2 + ++ – – 20.3± 1.3 16.22±5.1
55 2 + ++ – + 20.8± 1.3 30.47±10
(Continued)
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TABLE 3 | Continued
Isolate IC Carb R. Bio Hemo Sidero Motility (mm) Proteo (U/L) DT (hours)
56 10 - ++ α/D3 + 31.5± 2.1 11.64±2.02
57 2 + + α/D2 – 21.8± 1.1 25.32±2.73
58 2 + – α/D1 – 11.1± 0.6 24.49±4.55
59 2 + ++ α/D2 – 22.1± 1.2 13.81±4.49
60 2 + ++ – – 24.6± 1.8 8.37±2.92
61 2 + ++ α/D3 + 21.7± 1.1 21.61±0.24
62 4 – ++ α/D2 – 23.2± 1.4 7.3±0.21
63 2 + ++ α/D1 – 11.1± 0.7 4.4±1.63
64 2 – + α/D1 – 13.7± 0.6 10.6±1.45 0.339± 0.065
65 2 + ++ α/D2 – 25.2± 1.9 7.38±3.81
66 2 + ++ α/D2 – 27.1± 2.2 27.41±2.87 0.369± 0.021
67 2 + ++ α/D2 + 30.7± 1.9 22.94±2.87
68 2 + ++ – – 30± 2.2 22.64±7.44
69 2 + ++ – – 31.2± 2.8 28.3±2.1 0.385± 0.056
70 2 + ++ α/D2 – 32.3± 1.7 22.05±6.94
71 2 + ++ – – 28.3± 2 26.81±3.1
72 14 + ++ α/D3 + 20.2± 1.3 22.34±2.36
73 2 + ++ α/D1 – 34.7± 2.5 11.08±5.56
74 2 + ++ α/D2 – 28.3± 1.5 9.17±0.93
75 2 + ++ α/D2 – 22.3± 1.8 8.45±3.1 0.328± 0.076
76 2 + ++ α/D3 + 24.6± 1.8 27.41±4.03 0.311± 0.021
77 2 + ++ – + 23.1± 5.9 12.02±1.96
78 2 + ++ – – 35.7± 2 12.94±2.61 0.262± 0.021
79 2 + ++ – + 32.7± 1.8 11.13±0.69
80 2 + + α/D2 – 35.5± 1.8 22.94±2.87
81 2 + ++ α/D3 – 39.2± 1.5 26.81±0.89
82 4 + – – – 11.1± 0.7 8.28±0.33
83 2 + + – – 28.6± 2.4 20.85±4.5
84 2 + ++ – – 28.9± 2.3 3.21±3.04
85 2 + ++ – – 47.8± 2.6 8.49±2.85
86 2 + ++ – – 24.6± 1.5 6.54±4.7
87 2 – ++ – + 23.4± 1.9 13.9±4.48
89 2 + ++ – – 41.5± 2.3 21.81±8.09
90 2 + ++ α/D2 – 47.9± 2.9 23.56±10.31
91 4 + + α/D3 – 16.2± 1 25.14±2.31
92 2 + ++ – – 41.4± 2.1 6.04±3.49
93 2 + ++ α/D3 – 44.3± 2.5 24.55±9.35
94 2 – ++ α/D2 – 144.5± 7.7 26.37±4.42
95 2 + ++ – – 46.6± 2.7 23.65±8.61 0.414± 0.025
IC stands for international clone, Carb R. for carbapenem resistance, Bio for biofilm production, Hemo for hemolysis where the type of hemolysis and the day (D1–D3) on which it was
first observed was recorded, Sidero for siderophore production, Proteo for proteolytic activity, and DT for doubling times.
to carbapenems and had similar virulence profiles as isolates
pertaining to IC II. Both isolates that harbored blaOXA−24−like in
addition to blaOXA−23−like were negative for hemolysis and had
similar virulence profiles.
Associations between Virulence and
Resistance
IC II was positively associated with both carbapenem resistance
and harboring blaOXA−23−like (p < 0.01). All the isolates that
did not produce biofilms were also negative for siderophore
production. The isolates that showed moderate motility diffusion
patterns were associated with strong biofilm formation (p< 0.01)
while those that were either highly motile or non-motile showed
a positive association with siderophore production (p< 0.05). No
other statistical association were made.
DISCUSSION
In this study, A. baumannii isolates obtained from a major
tertiary care center in Beirut, Lebanon were characterized
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FIGURE 1 | Representative isolates showing (from left to right) no motility, moderate motility, and high motility.
in terms of antibiotic susceptibility, clonality, and virulence
determinants. An extremely high rate of carbapenem resistance
(90%) was detected among the A. baumannii isolates. This rate,
however, is very similar to that reported from a nation-wide
study (Hammoudi et al., 2015a) where the prevalence of CRAB
isolates was 88%. These findings suggest an immediate need for
the implementation of effective infection control measures and
antibiotic stewardship programs in Lebanese hospitals. This need
is even more urgent due to the high resistance rates of these
isolates to other antimicrobial agents that were tested for in this
study (Table 2). The low rate of resistance to colistin among these
isolates hold a viable alternative for treatment. Nevertheless, its
nephrotoxic effects (Bergen et al., 2012) and the ability of A.
baumannii to develop resistance toward this antimicrobial agent
during therapy (Valencia et al., 2009) limits its effectiveness.
In accordance with other studies performed in Lebanon,
IC II was by far the most prevalent clone among the A.
baumannii isolates (Rafei et al., 2014) and OXA-23-like is the
most disseminated (Rafei et al., 2015). These findings are also
similar to those reported from other Mediterranean countries
(Di Popolo et al., 2011). Interestingly, although an outbreak
caused by blaOXA−58−like harboring CRAB isolates was reported
from SGH-UMC a few years ago (Zarrilli et al., 2008), this
carbapenemase was not detected among our isolates. This could
be an indication of the successful eradication of the clone that
caused the outbreak at the time of that study.
The presence of blaOXA−23−like in two carbapenem-sensitive
isolates suggest that either the expression of this gene in these
isolates is very modest or that it harbors a mutation that
renders it ineffective. Further characterization of these isolates
by sequencing the genetic environment of blaOXA−23−like and
preforming RT-PCRs could help in better understanding why no
carbapenem resistance was detected in these isolates. The seven
CRAB isolates in which no carbapenemase was detected could
be expressing resistance through carbapenemases that were not
tested for in this study and/or through alteration of membrane
permeability and eﬄux pump over-expression (Peleg et al., 2008).
Ten CRAB isolates pertaining to PCR group 4 were first
identified in a study investigating A. baumannii isolates from
several European countries (Towner et al., 2008). In our study,
two out of the six isolates pertaining to this group were
susceptible to carbapenems. Similarly, the isolate pertaining
to group 10 was sensitive to carbapenems as opposed to the
detection of carbapenem resistance among isolates pertaining
to this group in a study in Portugal (Grosso et al., 2011).
The two isolates pertaining to group 14 were both resistant to
carbapenems. One of them did not harbor any of the tested
carbapenemases while the other had both OXA-23-like and
OXA-24-like. This group was first identified in a study from
Romanian hospitals and the isolate pertaining to this group
harbored blaOXA−58−like (Bonnin et al., 2011). The diversity
of profiles between the isolates pertaining to these groups, in
addition to the diversity seen among isolates pertaining to IC II,
reflect the plasticity of the A. baumannii genome (Antunes et al.,
2014). Moreover, the presence of these clones, in addition to the
presence of the globally disseminated IC II (Karah et al., 2012),
show the global expansion of A. baumannii clones that are able
to expand to wide geographical areas.
A study by Antunes et al. (2011) showed that different A.
baumannii clinical isolates are able to display different virulence
profiles. This was indeed shown to be the case in our study where
no specific pattern of virulence was associated with a specific
clone (Table 3). The A. baumannii isolates investigated had a
high degree of variability in terms of virulence profiles. Moreover,
no associations between antibiotic susceptibility profiles and
doubling times were detected. These findings suggest that each
isolate should be treated as a unique case and no general
assumptions could be made based on clonality and AST.
This also shows that the relationship between virulence and
antibiotic resistance is indeed a complex one andwarrants further
investigation (Peleg et al., 2012). Nevertheless, the low diversity of
clones among the tested isolates could be obscuring associations
between clonality and virulence, since some isolates pertaining to
group 4 and those pertaining to group 14 had similar virulence
profiles. Further investigating these associations using larger and
more clonally diversified pools could shed further light on the
matter. Interestingly, the motility diffusion patterns that were
obtained in our study using Difco agar were circular, as opposed
to the linear patterns reported while using this kind of agar by
Clemmer et al. (2011). The patterns obtained in our study are
rather similar to those obtained using Eiken agar. The reason for
this difference is still not clear at this point, but could possibly be
due to an experimental factor that is independent from the agar
brand, or is a property pertaining to the particular strains that
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were tested for in the different studies. This, however, requires
further investigation before verification.
Finally, while comparing virulence factors one to another,
an association between motility on one hand, and biofilm
formation and siderophore production on the other, was
determined. The relationship between motility and strong
biofilm formation has been previously reported among
MDR A. baumannii isolates (Eijkelkamp et al., 2011b).
Moreover, the association detected between motility and
siderophore production is not surprising since the former
factor was associated with biofilm production while the
latter allows for iron acquisition that is crucial for biofilm
formation (Gentile et al., 2014). These associations reveal
a highly complex interplay between the different virulence
determinants in A. baumannii, especially those that are
multi-factorial.
CONCLUSIONS
In conclusion, a very high rate of carbapenem resistance was
detected among clinical A. baumannii isolates obtained from
a Lebanese tertiary care center. IC II was the most prevalent
clone and OXA-23-like was the most prevalent carbapenemase.
The isolates showed highly varied virulence profiles that were
not associated with any specific clone or oxacillinase gene.
However, associations between motility, biofilm formation, and
siderophore production have been found. Increasing the diversity
of the pool of isolates could reveal associations between clonality
and virulence that could allow for the prediction of pathogenicity
of a clinical A. baumannii isolate.
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